Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9855335 | AMNEAL | Tigecycline composition for injection |
Apr, 2033
(10 years from now) |
Market Authorisation Date: 02 August, 2018
Treatment: NA
Dosage: POWDER;INTRAVENOUS
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9254328 | PF PRISM CV | Tigecycline compositions and methods of preparation |
Mar, 2026
(3 years from now) | |
US9694078 | PF PRISM CV | Tigecycline compositions and methods of preparation |
Mar, 2026
(3 years from now) | |
US10588975 | PF PRISM CV | Tigecycline compositions and methods of preparation |
Mar, 2026
(3 years from now) | |
US8975242 | PF PRISM CV | Tigecycline compositions and methods of preparation |
Oct, 2028
(5 years from now) | |
US7879828 | PF PRISM CV | Tigecycline compositions and methods of preparation |
Feb, 2029
(6 years from now) | |
US8372995 | PF PRISM CV | Crystalline solid forms of tigecycline and methods of preparing same |
Oct, 2030
(7 years from now) |
Market Authorisation Date: 15 June, 2005
Treatment: NA
Dosage: POWDER;INTRAVENOUS
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic